UBS Group
AVNS

UBS Group’s Avanos Medical AVNS Stock Holding History

UBS Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-300
Closed -$14K – 8793
2014
Q4 		$14K Buy
+300
New +$11.8K ﹤0.01% 8075

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

UBS Group's AVNS Position: Q2 2026 in Review

UBS Group increased its Avanos Medical (AVNS) stake by 110% in Q2 2026, buying an estimated $3.43M and bringing the position to 279,381 shares worth $6.95M. The position accounts for ﹤0.01% of the portfolio, ranked #3834.

UBS Group first reported a position in AVNS in Q4 2014 and has held it in 47 quarters since. The position peaked at $10.2M in Q4 2014. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • UBS Group held 279,381 shares of Avanos Medical worth $6.95M as of Q2 2026.
  • UBS Group bought 146,646 Avanos Medical shares in Q2 2026, an estimated $3.43M.
  • Avanos Medical made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3834 holding.
  • UBS Group first reported a position in Avanos Medical in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Avanos Medical position peaked at $10.2M in Q4 2014.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.